In Coding
Mar 2nd, 2012
For the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy, you would be correct to report HCPCS Level II code Q2044 Injection, belimumab, 10 mg for dates of service July 1, 2011 through Dec. 31, 2011. For 2012, however, at least one Medicare administrative contractor (MAC) has indicated ...
In Billing
Jun 10th, 2011
The July 1 update of the Ambulatory Surgical Center (ASC) payment system brings changes to the ASC rates, payment indicators, and separately paid drugs and biologicals, as announced by the Centers for Medicare & Medicaid Services (CMS) in a transmittal released June 3. Notable changes include the addition of six, separately payable Category III CPT® ...
In Billing
Jun 10th, 2011
In a transmittal release May 27, the Centers for Medicare & Medicaid Services (CMS) describes the July 2011 update of the hospital Outpatient Prospective Payment System (OPPS). Added codes include: C9730 Bronchoscopic bronchial thermoplasty with imaging guidance (if performed), radiofrequency ablation of airway smooth muscle; 1 lobe C9731 Bronchoscopic bronchial thermoplasty with imaging guidan...
In Billing
May 31st, 2011
Updated payment files for the Medicare Physician Fee Schedule (MPFS) were released to contractors May 20. The files include several changes to HCPCS Level II and CPT® code descriptors and payment indicators. The list of Medicare-covered codes also grew. Medicare contractors were instructed to implement the updated payment files by July 5. Included in the updated payment ...
In CMS
May 13th, 2011
The July 1 quarterly HCPCS Level II update includes a handful of important drug/biological code changes. Effective July 1, HCPCS Level II code J7184 will be directly replaced with Q2041 Injection, Von Willebrand factor complex (human), Wilate, per 100 IU VWF RCo, which describes Wilate® for intravenous injection for spontaneous or trauma-induced bleeding in patients ...